- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 07.01. | GSK's Nucala approved by MHRA for uncontrolled COPD | ||
| 07.01. | Amgen agrees to lower prescription drug costs in deal with US government | ||
| 06.01. | Gilead agrees on affordable medicines plan with US government | ||
| 06.01. | Novartis agrees to lower drug prices in deal with US government | ||
| 05.01. | Merck announces agreement with US government to reduce prices of prescription medication | ||
| 05.01. | Novo Nordisk's Wegovy approved by FDA as oral medication for weight management | ||
| 19.12.25 | Galderma's Nemluvio rapidly relieves atopic dermatitis and prurigo nodularis symptoms | ||
| 19.12.25 | Lilly announces new study data on Inluriyo in metastatic breast cancer | ||
| 18.12.25 | The next era in life sciences: agentic AI and other innovations transforming HCP engagement | ||
| 18.12.25 | Scaling AI in healthcare communications: from pilots to living systems | ||
| 18.12.25 | Clicks vs credibility: how social media underscores patient understanding | ||
| 18.12.25 | How smart scaling and strategic implementation of AI are transforming life sciences | ||
| 18.12.25 | PMLiVE's T40 2025 - results announced! | ||
| 18.12.25 | Nektar Therapeutics announces top-line results from alopecia areata study | ||
| 18.12.25 | Havas Life London unveils AI awareness campaign | ||
| 17.12.25 | AstraZeneca's Enhertu combination approved by FDA for HER2-positive breast cancer | ||
| 17.12.25 | Medicus Pharma completes patient enrolment for basal cell carcinoma trial | ||
| 16.12.25 | FDA approves first gene therapy for Wiskott-Aldrich syndrome | ||
| 16.12.25 | Researchers at University of Geneva develop test platform for cancer treatments | ||
| 15.12.25 | Lilly and Indiana University collaborate to expand clinical trial access | ||
| 15.12.25 | CGT Catapult establishes industry safety consortium for cell therapies | ||
| 12.12.25 | The trust crisis: how pharma must evolve to engage Gen Z HCPs | ||
| 12.12.25 | Lilly announces plans for $6bn US manufacture facility | ||
| 12.12.25 | Kymera reports positive results in clinical trial for atopic dermatitis | ||
| 11.12.25 | FDA launches TEMPO digital health pilot |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.